EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to tame rare blood and vessel diseases in kids
Disease control Recruiting nowThis study is testing a drug called benralizumab in children aged 6 to 18 with rare diseases where a type of white blood cell (eosinophils) causes inflammation and organ damage. The main goal is to see if the drug is safe and effective at controlling disease flares and reducing t…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Pregnant with vasculitis? researchers want to hear your story
Knowledge-focused Recruiting nowThis study aims to understand how different types of vasculitis affect pregnancy experiences and outcomes. Researchers are inviting pregnant women with various vasculitis conditions to complete online surveys during their second trimester, third trimester, and after delivery. The…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists map skin clues in mysterious blood vessel diseases
Knowledge-focused Recruiting nowThis study aims to learn more about how different types of vasculitis affect the skin. Researchers will collect small skin samples (biopsies) from people who have active skin lesions caused by their vasculitis. By analyzing these samples, they hope to better describe and understa…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC